Indications And Usage Enalaprilat Injection Is Indicated For The Treatment Of Hypertension When Oral Therapy Is Not Practical. Enalaprilat Injection Has Been Studied With Only One Other Antihypertensive Agent, Furosemide, Which Showed Approximately Additive Effects On Blood Pressure. Enalapril, The Pro-Drug Of Enalaprilat, Has Been Used Extensively With A Variety Of Other Antihypertensive Agents, Without Apparent Difficulty Except For Occasional Hypotension. In Using Enalaprilat Injection, Consideration Should Be Given To The Fact That Another Angiotensin Converting Enzyme Inhibitor, Captopril, Has Caused Agranulocytosis, Particularly In Patients With Renal Impairment Or Collagen Vascular Disease, And That Available Data Are Insufficient To Show That Enalaprilat Injection Does Not Have A Similar Risk. (See Warnings .) In Considering Use Of Enalaprilat Injection, It Should Be Noted That In Controlled Clinical Trials Ace Inhibitors Have An Effect On Blood Pressure That Is Less In Black Patients Than In Non-Blacks. In Addition, It Should Be Noted That Black Patients Receiving Ace Inhibitors Have Been Reported To Have A Higher Incidence Of Angioedema Compared To Non-Blacks. (See Warnings, Head And Neck Angioedema ).
|